SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-007586
Filing Date
2024-02-28
Accepted
2024-02-28 16:10:14
Documents
14
Period of Report
2024-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20240227.htm   iXBRL 8-K 27427
  Complete submission text file 0001628280-24-007586.txt   159925

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20240227.xsd EX-101.SCH 1889
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20240227_lab.xml EX-101.LAB 26155
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20240227_pre.xml EX-101.PRE 13573
15 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20240227_htm.xml XML 2865
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 24695419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)